
NATURE . COM {
}
Title:
1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells | Cell Death & Disease
Description:
Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.
Keywords {🔍}
cells, irx, gefitinib, cancer, nanog, cell, expression, pcgr, fig, article, resistance, properties, google, scholar, china, lung, western, cas, stemlike, ohd, treatment, stem, blotting, protein, nsclc, tumor, signaling, combination, tgfβ, cytotoxicity, results, group, analysis, nature, egfrtki, increased, inhibited, stemness, experiments, transfected, usa, sirna, growth, celllike, treated, significantly, levels, assay, nanjing, viability,
Topics {✒️}
nature portfolio beta-catenin-mediated epithelial-mesenchymal transition vdr/plc-gamma1/tgf-beta1/pathway serum‐free opti‐mem media research groups privacy policy tgf-β/smad signaling-induced irx4 tgf-β1/smad3 signaling pathway tgf-β/smad signaling pathway28 nature small-molecule multi-kinase inhibitor20 advertising erk1/2-mzf1 signaling pathway reprints tgf-β1/smad3 signaling japan activating stat3/cxcl1 axis 2d3 signaling-induced decreases egfr-tyrosine kinase inhibitors small-cell lung cancer egfr-tki resistant cells irx4-mediated cancer stem potentiates cell death social media poor egfr-tki sensitivity inhibit egfr-tki resistance irx4-expressing cell lines nanog-mediated stem cell state key laboratory regulating egfr-tki resistance cd44+cd133+ pc-9/gr cells increase egfr-tki resistance high tgf-β1 levels irx-family genes participate egfr-mutant nsclc cells9 contract number hh20190622lhy-lv03 ventricular-specific progenitor cell multi-directional differentiation potential pnanog-luc reporter activity irx4+mouse embryonic cells original author tgf-β1 induced permissions sirna/plasmid‐lipid complexes lung cancer progression tyrosine kinase inhibitors 20 ng/ml tgf-β1 delayed development cell death dis pre-clinical models support
Questions {❓}
- How IRX4 controls gefitinib cytotoxicity?
- How to regulate IRX4-mediated cancer stem-like properties and gefitinib resistance?
Schema {🗺️}
WebPage:
mainEntity:
headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
datePublished:2020-08-20T00:00:00Z
dateModified:2020-08-20T00:00:00Z
pageStart:1
pageEnd:15
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41419-020-02908-w
keywords:
Cancer
Cancer therapy
Life Sciences
general
Biochemistry
Cell Biology
Immunology
Cell Culture
Antibodies
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
isPartOf:
name:Cell Death & Disease
issn:
2041-4889
volumeNumber:11
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Zhirong Jia
url:http://orcid.org/0000-0002-7381-5150
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Yameng Zhang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Aiwen Yan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Meisa Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Qiushuang Han
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Kaiwei Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Jie Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:the First Affiliated Hospital of Xinjiang Medical University
address:
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
type:PostalAddress
type:Organization
type:Person
name:Chen Qiao
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Zhenzhen Pan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Chuansheng Chen
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Dong Hu
affiliation:
name:Anhui University of Science and Technology
address:
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Xuansheng Ding
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
datePublished:2020-08-20T00:00:00Z
dateModified:2020-08-20T00:00:00Z
pageStart:1
pageEnd:15
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41419-020-02908-w
keywords:
Cancer
Cancer therapy
Life Sciences
general
Biochemistry
Cell Biology
Immunology
Cell Culture
Antibodies
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
isPartOf:
name:Cell Death & Disease
issn:
2041-4889
volumeNumber:11
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Zhirong Jia
url:http://orcid.org/0000-0002-7381-5150
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Yameng Zhang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Aiwen Yan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Meisa Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Qiushuang Han
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Kaiwei Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Jie Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:the First Affiliated Hospital of Xinjiang Medical University
address:
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
type:PostalAddress
type:Organization
type:Person
name:Chen Qiao
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Zhenzhen Pan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Chuansheng Chen
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Dong Hu
affiliation:
name:Anhui University of Science and Technology
address:
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Xuansheng Ding
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Cell Death & Disease
issn:
2041-4889
volumeNumber:11
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:the First Affiliated Hospital of Xinjiang Medical University
address:
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:Anhui University of Science and Technology
address:
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Zhirong Jia
url:http://orcid.org/0000-0002-7381-5150
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Yameng Zhang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Aiwen Yan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Meisa Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Qiushuang Han
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Kaiwei Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Jie Wang
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:the First Affiliated Hospital of Xinjiang Medical University
address:
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
type:PostalAddress
type:Organization
name:Chen Qiao
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Zhenzhen Pan
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Chuansheng Chen
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:Dong Hu
affiliation:
name:Anhui University of Science and Technology
address:
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
type:PostalAddress
type:Organization
email:[email protected]
name:Xuansheng Ding
affiliation:
name:China Pharmaceutical University
address:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
name:China Pharmaceutical University
address:
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
External Links {🔗}(114)
- How profitable is https://orcid.org/0000-0002-7381-5150?
- Learn about the earnings of https://doi.org/10.1016%2FS0140-6736%2817%2933326-3
- How much does http://scholar.google.com/scholar_lookup?&title=Global%20surveillance%20of%20trends%20in%20cancer%20survival%202000-14%20%28CONCORD-3%29%3A%20analysis%20of%20individual%20records%20for%2037%20513%20025%20patients%20diagnosed%20with%20one%20of%2018%20cancers%20from%20322%20population-based%20registries%20in%2071%20countries&journal=Lancet&doi=10.1016%2FS0140-6736%2817%2933326-3&volume=391&pages=1023-1075&publication_year=2018&author=Allemani%2CC net monthly?
- What's the profit of https://doi.org/10.1200%2FJCO.2012.45.3753?
- How much does http://scholar.google.com/scholar_lookup?&title=Genotyping%20and%20genomic%20profiling%20of%20non-small-cell%20lung%20cancer%3A%20implications%20for%20current%20and%20future%20therapies&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2012.45.3753&volume=31&pages=1039-1049&publication_year=2013&author=Li%2CT&author=Kung%2CHJ&author=Mack%2CPC&author=Gandara%2CDR gross monthly?
- What are the total earnings of https://doi.org/10.6004%2Fjnccn.2018.0062?
- How much does http://scholar.google.com/scholar_lookup?&title=NCCN%20guidelines%20insights%3A%20non-small%20cell%20lung%20cancer%2C%20Version%205.2018&journal=J.%20Natl%20Compr.%20Canc%20Netw.&doi=10.6004%2Fjnccn.2018.0062&volume=16&pages=807-821&publication_year=2018&author=Ettinger%2CDS generate monthly?
- Profit of https://doi.org/10.1038%2Fcddis.2014.447
- How much does http://scholar.google.com/scholar_lookup?&title=A%20novel%20antagonist%20to%20the%20inhibitors%20of%20apoptosis%20%28IAPs%29%20potentiates%20cell%20death%20in%20EGFR-overexpressing%20non-small-cell%20lung%20cancer%20cells&journal=Cell%20Death%20Dis.&doi=10.1038%2Fcddis.2014.447&volume=5&publication_year=2014&author=Lee%2CSH generate monthly?
- How much income is https://doi.org/10.2174%2F1574887114666181205155211 earning monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Advanced%20non-small%20cell%20lung%20cancer%20with%20activating%20epidermal%20growth%20factor%20receptor%20mutation%3A%20first%20line%20treatment%20and%20beyond&journal=Rev.%20Recent%20Clin.%20Trials&doi=10.2174%2F1574887114666181205155211&volume=14&pages=120-128&publication_year=2019&author=Rocco%2CD&author=Battiloro%2CC&author=Gravara%2CLD&author=Gridelli%2CC makes per month
- What is the earnings of https://link.springer.com/doi/10.1007/s40264-018-0772-x?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Safety%20and%20tolerability%20of%20epidermal%20growth%20factor%20receptor%20%28EGFR%29%20tyrosine%20kinase%20inhibitors%20in%20oncology&journal=Drug%20Saf.&doi=10.1007%2Fs40264-018-0772-x&volume=42&pages=181-198&publication_year=2019&author=Shah%2CRR&author=Shah%2CDR
- What's the revenue for https://doi.org/10.1016%2Fj.resinv.2018.09.001?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Resistance%20to%20molecularly%20targeted%20therapy%20in%20non-small-cell%20lung%20cancer&journal=Respir.%20Investig.&doi=10.1016%2Fj.resinv.2018.09.001&volume=57&pages=20-26&publication_year=2019&author=Asao%2CT&author=Takahashi%2CF&author=Takahashi%2CK
- Monthly income for https://doi.org/10.1111%2Fcas.12749
- How much money does http://scholar.google.com/scholar_lookup?&title=Acquisition%20of%20cancer%20stem%20cell-like%20properties%20in%20non-small%20cell%20lung%20cancer%20with%20acquired%20resistance%20to%20afatinib&journal=Cancer%20Sci.&doi=10.1111%2Fcas.12749&volume=106&pages=1377-1384&publication_year=2015&author=Hashida%2CS make?
- How much does https://doi.org/10.1038%2Fs41467-018-05626-2 pull in monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Notch3-dependent%20beta-catenin%20signaling%20mediates%20EGFR%20TKI%20drug%20persistence%20in%20EGFR%20mutant%20NSCLC&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-018-05626-2&volume=9&publication_year=2018&author=Arasada%2CRR
- How much profit is https://doi.org/10.1111%2Fcrj.12976 making per month?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=CD146-mediated%20acquisition%20of%20stemness%20phenotype%20enhances%20tumour%20invasion%20and%20metastasis%20after%20EGFR-TKI%20resistance%20in%20lung%20cancer&journal=Clin.%20Respir.%20J.&doi=10.1111%2Fcrj.12976&volume=13&pages=23-33&publication_year=2019&author=Zhang%2CF
- What is the earnings of https://doi.org/10.1158%2F0008-5472.CAN-12-4136?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20EGFR%20inhibitors%20is%20associated%20with%20a%20manifestation%20of%20stem%20cell-like%20properties%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-12-4136&volume=73&pages=3051-3061&publication_year=2013&author=Shien%2CK is on a monthly basis
- See how much https://doi.org/10.1016%2Fj.canlet.2018.07.020 makes per month
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Genome-wide%20identification%20of%20transcription%20factors%20that%20are%20critical%20to%20non-small%20cell%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2018.07.020&volume=434&pages=132-143&publication_year=2018&author=Zhang%2CDL each month?
- What is the monthly revenue of https://link.springer.com/doi/10.1007/s00429-016-1326-6?
- How much does http://scholar.google.com/scholar_lookup?&title=Expression%20patterns%20of%20Irx%20genes%20in%20the%20developing%20chick%20inner%20ear&journal=Brain%20Struct.%20Funct.&doi=10.1007%2Fs00429-016-1326-6&volume=222&pages=2071-2092&publication_year=2017&author=Cardena-Nunez%2CS earn?
- What's the profit of https://doi.org/10.1038%2Fncomms1301?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=An%20evolutionarily%20conserved%20three-dimensional%20structure%20in%20the%20vertebrate%20Irx%20clusters%20facilitates%20enhancer%20sharing%20and%20coregulation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1301&volume=2&publication_year=2011&author=Tena%2CJJ
- How much does https://doi.org/10.1002%2Fstem.2486 net monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Irx4%20marks%20a%20multipotent%2C%20ventricular-specific%20progenitor%20cell&journal=Stem%20Cells&doi=10.1002%2Fstem.2486&volume=34&pages=2875-2888&publication_year=2016&author=Nelson%2CDO?
- What's the profit of https://doi.org/10.1016%2Fj.mcn.2008.11.003?
- http://scholar.google.com/scholar_lookup?&title=Formation%20of%20posterior%20cranial%20placode%20derivatives%20requires%20the%20Iroquois%20transcription%20factor%20irx4a&journal=Mol.%20Cell%20Neurosci.&doi=10.1016%2Fj.mcn.2008.11.003&volume=40&pages=328-337&publication_year=2009&author=Feijoo%2CCG&author=Saldias%2CMP&author=Paz%2CJF&author=Gomez-Skarmeta%2CJL&author=Allende%2CML income
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22213310 making per month?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Vitamin%20D%3A%20potential%20in%20the%20prevention%20and%20treatment%20of%20lung%20cancer&journal=Anticancer%20Res.&volume=32&pages=211-221&publication_year=2012&author=Norton%2CR&author=O%E2%80%99Connell%2CMA?
- How much does https://doi.org/10.1016%2Fj.jsbmb.2012.09.022 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Differential%20response%20to%201alpha%2C25-dihydroxyvitamin%20D3%20%281alpha%2C25%28OH%292D3%29%20in%20non-small%20cell%20lung%20cancer%20cells%20with%20distinct%20oncogene%20mutations&journal=J.%20Steroid%20Biochem%20Mol.%20Biol.&doi=10.1016%2Fj.jsbmb.2012.09.022&volume=136&pages=264-270&publication_year=2013&author=Zhang%2CQ pull in monthly?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31002352?
- How much does http://scholar.google.com/scholar_lookup?&title=1alpha%2C25Dihydroxyvitamin%20D3%20restrains%20stem%20celllike%20properties%20of%20ovarian%20cancer%20cells%20by%20enhancing%20vitamin%20D%20receptor%20and%20suppressing%20CD44&journal=Oncol.%20Rep.&volume=41&pages=3393-3403&publication_year=2019&author=Ji%2CM&author=Liu%2CL&author=Hou%2CY&author=Li%2CB pull in monthly?
- How much revenue does https://doi.org/10.1016%2Fj.stem.2018.11.017 bring in?
- How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20cancer%20stemness%20in%20the%20clinic%3A%20from%20hype%20to%20hope&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2018.11.017&volume=24&pages=25-40&publication_year=2019&author=Saygin%2CC&author=Matei%2CD&author=Majeti%2CR&author=Reizes%2CO&author=Lathia%2CJD net monthly?
- How much revenue does https://doi.org/10.1016%2Fj.canlet.2019.03.027 produce monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Protective%20autophagy%20decreases%20osimertinib%20cytotoxicity%20through%20regulation%20of%20stem%20cell-like%20properties%20in%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2019.03.027&volume=452&pages=191-202&publication_year=2019&author=Li%2CL generate?
- Check the income stats for https://doi.org/10.1038%2Fs41388-018-0589-1
- Profit of http://scholar.google.com/scholar_lookup?&title=Cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20are%20dependent%20on%20purine%20synthetic%20metabolism%20mediated%20by%20the%20mitochondrial%20enzyme%20MTHFD2&journal=Oncogene&doi=10.1038%2Fs41388-018-0589-1&volume=38&pages=2464-2481&publication_year=2019&author=Nishimura%2CT
- How much revenue does https://doi.org/10.18632%2Foncotarget.3389 produce monthly?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=IL-8%20confers%20resistance%20to%20EGFR%20inhibitors%20by%20inducing%20stem%20cell%20properties%20in%20lung%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.3389&volume=6&pages=10415-10431&publication_year=2015&author=Liu%2CYN?
- How much cash flow does https://doi.org/10.1002%2Fstem.29 have monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Functional%20evidence%20that%20the%20self-renewal%20gene%20NANOG%20regulates%20human%20tumor%20development&journal=Stem%20Cells&doi=10.1002%2Fstem.29&volume=27&pages=993-1005&publication_year=2009&author=Jeter%2CCR
- What's the revenue for https://doi.org/10.1158%2F0008-5472.CAN-10-3320?
- How much does http://scholar.google.com/scholar_lookup?&title=HIF%20induces%20human%20embryonic%20stem%20cell%20markers%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-10-3320&volume=71&pages=4640-4652&publication_year=2011&author=Mathieu%2CJ rake in every month?
- How much does https://doi.org/10.1016%2Fj.suronc.2013.08.001 generate monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Nanog%2C%20a%20novel%20prognostic%20marker%20for%20lung%20cancer&journal=Surg.%20Oncol.&doi=10.1016%2Fj.suronc.2013.08.001&volume=22&pages=224-229&publication_year=2013&author=Du%2CY
- What is the earnings of https://doi.org/10.1158%2F1078-0432.CCR-14-2437?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Activation%20of%20vitamin%20D%20receptor%20signaling%20downregulates%20the%20expression%20of%20nuclear%20FOXM1%20protein%20and%20suppresses%20pancreatic%20cancer%20cell%20stemness&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-14-2437&volume=21&pages=844-853&publication_year=2015&author=Li%2CZ
- Find out how much https://doi.org/10.1111%2Fcas.14237 earns monthly
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Calcitriol%20inhibits%20migration%20and%20invasion%20of%20renal%20cell%20carcinoma%20cells%20by%20suppressing%20Smad2%2F3-%2C%20STAT3-%20and%20beta-catenin-mediated%20epithelial-mesenchymal%20transition&journal=Cancer%20Sci.&doi=10.1111%2Fcas.14237&volume=111&pages=59-71&publication_year=2020&author=Xu%2CS?
- How much income does https://doi.org/10.1016%2Fj.molimm.2017.09.006 have?
- What's the income of http://scholar.google.com/scholar_lookup?&title=1%2C25%28OH%292D3%20induces%20regulatory%20T%20cell%20differentiation%20by%20influencing%20the%20VDR%2FPLC-gamma1%2FTGF-beta1%2Fpathway&journal=Mol.%20Immunol.&doi=10.1016%2Fj.molimm.2017.09.006&volume=91&pages=156-164&publication_year=2017&author=Zhou%2CQ?
- How much revenue does https://doi.org/10.1038%2Fs41556-018-0062-y bring in?
- How much does http://scholar.google.com/scholar_lookup?&title=PSPC1%20mediates%20TGF-beta1%20autocrine%20signalling%20and%20Smad2%2F3%20target%20switching%20to%20promote%20EMT%2C%20stemness%20and%20metastasis&journal=Nat.%20Cell%20Biol.&doi=10.1038%2Fs41556-018-0062-y&volume=20&pages=479-491&publication_year=2018&author=Yeh%2CHW pull in?
- What are the total earnings of https://doi.org/10.1111%2Ffebs.14162?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=TGF-beta1-induced%20CK17%20enhances%20cancer%20stem%20cell-like%20properties%20rather%20than%20EMT%20in%20promoting%20cervical%20cancer%20metastasis%20via%20the%20ERK1%2F2-MZF1%20signaling%20pathway&journal=FEBS%20J.&doi=10.1111%2Ffebs.14162&volume=284&pages=3000-3017&publication_year=2017&author=Wu%2CL?
- https://doi.org/10.1016%2Fj.biopha.2015.10.018's total income per month
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=TGF-beta1%20induces%20erlotinib%20resistance%20in%20non-small%20cell%20lung%20cancer%20by%20down-regulating%20PTEN&journal=Biomed.%20Pharmacother.&doi=10.1016%2Fj.biopha.2015.10.018&volume=77&pages=1-6&publication_year=2016&author=Shen%2CH?
- How much income does https://doi.org/10.1158%2F1535-7163.MCT-13-0448 have?
- http://scholar.google.com/scholar_lookup?&title=MiR-134%2F487b%2F655%20cluster%20regulates%20TGF-beta-induced%20epithelial-mesenchymal%20transition%20and%20drug%20resistance%20to%20gefitinib%20by%20targeting%20MAGI2%20in%20lung%20adenocarcinoma%20cells&journal=Mol.%20Cancer%20Ther.&doi=10.1158%2F1535-7163.MCT-13-0448&volume=13&pages=444-453&publication_year=2014&author=Kitamura%2CK income
- How much does https://doi.org/10.1038%2Fncomms1880 bring in each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Loss-of-function%20of%20inositol%20polyphosphate-4-phosphatase%20reversibly%20increases%20the%20severity%20of%20allergic%20airway%20inflammation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1880&volume=3&publication_year=2012&author=Aich%2CJ&author=Mabalirajan%2CU&author=Ahmad%2CT&author=Agrawal%2CA&author=Ghosh%2CB bring in?
- How much income does https://doi.org/10.1073%2Fpnas.1009472107 have?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=TGF-beta%20IL-6%20axis%20mediates%20selective%20and%20adaptive%20mechanisms%20of%20resistance%20to%20molecular%20targeted%20therapy%20in%20lung%20cancer&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.1009472107&volume=107&pages=15535-15540&publication_year=2010&author=Yao%2CZ produce monthly?
- Explore the financials of https://link.springer.com/doi/10.1186/s13046-019-1120-4
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Co-administration%20of%2020%28S%29-protopanaxatriol%20%28g-PPT%29%20and%20EGFR-TKI%20overcomes%20EGFR-TKI%20resistance%20by%20decreasing%20SCD1%20induced%20lipid%20accumulation%20in%20non-small%20cell%20lung%20cancer&journal=J.%20Exp.%20Clin.%20Cancer%20Res&doi=10.1186%2Fs13046-019-1120-4&volume=38&publication_year=2019&author=Huang%2CQ is on a monthly basis
- What is the monthly revenue of https://link.springer.com/doi/10.1186/s13046-018-0894-0?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=FOXC1%20induces%20cancer%20stem%20cell-like%20properties%20through%20upregulation%20of%20beta-catenin%20in%20NSCLC&journal=J.%20Exp.%20Clin.%20Cancer%20Res.&doi=10.1186%2Fs13046-018-0894-0&volume=37&publication_year=2018&author=Cao%2CS
- Monthly income for https://doi.org/10.1158%2F1078-0432.CCR-13-2613
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Metformin%20sensitizes%20EGFR-TKI-resistant%20human%20lung%20cancer%20cells%20in%20vitro%20and%20in%20vivo%20through%20inhibition%20of%20IL-6%20signaling%20and%20EMT%20reversal&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-13-2613&volume=20&pages=2714-2726&publication_year=2014&author=Li%2CL?
- How much does https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=references pull in monthly?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhirong%20Jia have?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhirong%20Jia%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yameng%20Zhang
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yameng%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aiwen%20Yan?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aiwen%20Yan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Meisa%20Wang's gross income?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Meisa%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qiushuang%20Han's revenue stream
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qiushuang%20Han%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kaiwei%20Wang each month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kaiwei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jie%20Wang bring in?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jie%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chen%20Qiao
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chen%20Qiao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhenzhen%20Pan generate?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhenzhen%20Pan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chuansheng%20Chen bring in?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chuansheng%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dong%20Hu?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dong%20Hu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xuansheng%20Ding?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xuansheng%20Ding%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- See how much http://creativecommons.org/licenses/by/4.0/ makes per month
- What's the financial outcome of https://s100.copyright.com/AppDispatchServlet?title=1%2C25-dihydroxyvitamin%20D3%20signaling-induced%20decreases%20in%20IRX4%20inhibits%20NANOG-mediated%20cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20in%20NSCLC%20cells&author=Zhirong%20Jia%20et%20al&contentID=10.1038%2Fs41419-020-02908-w©right=The%20Author%28s%29&publication=2041-4889&publicationDate=2020-08-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY?
- Discover the revenue of https://crossmark.crossref.org/dialog/?doi=10.1038/s41419-020-02908-w
- Get to know what's the income of https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=citation
- What is the earnings of https://doi.org/10.1007/s10555-024-10171-0?
- https://doi.org/10.1186/s12943-023-01877-w's revenue stream
- How much revenue does https://doi.org/10.1007/s12032-023-02210-7 bring in?
- What's the income generated by https://doi.org/10.1038/s41420-022-00918-5 each month?
- What is the monthly revenue of https://www.protocols.io/?
- How much does https://www.natureindex.com/ pull in monthly?
- Learn about the earnings of http://www.naturechina.com
- See how much https://www.natureasia.com/ja-jp makes per month
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref